Latest filing published 29 May 2018 for Wilson Therapeutics AB, €32k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Anders Martin-Löf: trading record in brief
All filings by Anders Martin-Löf on record concern Wilson Therapeutics AB. In total, 3 filings cover trades dated from 7 December 2016 to 25 May 2018.
On the open market, the record shows 2 purchases worth €7,952 and 1 sale worth €32k. Sales outweigh purchases by €24k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Since January 2018: no purchases and 1 sale on the market.
The record was last updated on 29 May 2018 with an open-market sale (€32k) in Wilson Therapeutics AB. The last insider purchase was made public on 7 December 2016, 3,623 days ago. Half of the filings or more reach the Finansinspektionen feed on the day of the trade. For comparison, MAR article 19 gives managers three business days to notify a trade. Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Anders Martin-Löf
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,400 shares@ SEK 232.0079.9% of flowISIN SE0008293674FI:csv-85c6bb93962724766ea8
- 700 shares@ SEK 55.5010.0% of flowISIN SE0008293674FI:csv-8d24f02dd66f18da1618Canonical exit: 7 Mar 2017 (T+90)
- 700 shares@ SEK 55.7510.1% of flowISIN SE0008293674FI:csv-42ca2218e815d114882eCanonical exit: 7 Mar 2017 (T+90)
3 of 3 declarations